Co-Authors
This is a "connection" page, showing publications co-authored by Maurizio Cecconi and Claudio Angelini.
Connection Strength
0.560
-
Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy. J Clin Med. 2020 May 20; 9(5).
Score: 0.221
-
Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19. Ann Intensive Care. 2021 Jun 04; 11(1):91.
Score: 0.059
-
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol. 2021 01; 22(1):19-24.
Score: 0.057
-
The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy. Int J Cardiol. 2021 02 01; 324:249-254.
Score: 0.057
-
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients. J Autoimmun. 2020 11; 114:102511.
Score: 0.056
-
High mortality in COVID-19 patients with mild respiratory disease. Eur J Clin Invest. 2020 Sep; 50(9):e13314.
Score: 0.056
-
Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020 10 15; 383(16):1522-1534.
Score: 0.055